ICAD 📈 icad inc - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US44934S2068
ICAD: Cancer, Detection, Therapy, Solutions, Breast, Imaging, Software
iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire. Web URL: https://www.icadmed.com
Additional Sources for ICAD Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ICAD Stock Overview
| Market Cap in USD | 47m |
| Sector | Healthcare |
| Industry | Medical Devices |
| GiC Sub-Industry | Health Care Technology |
| IPO / Inception | 1986-12-03 |
ICAD Stock Ratings
| Growth 5y | -72.4% |
| Fundamental | -56.9% |
| Dividend | - |
| Rel. Strength Industry | 112 |
| Analysts | 4.75/5 |
| Fair Price Momentum | 1.36 USD |
| Fair Price DCF | - |
ICAD Dividends
No Dividends PaidICAD Growth Ratios
| Growth Correlation 3m | 36.5% |
| Growth Correlation 12m | 19.5% |
| Growth Correlation 5y | -84.9% |
| CAGR 5y | -25.35% |
| CAGR/Mean DD 5y | -0.40 |
| Sharpe Ratio 12m | 0.43 |
| Alpha | -23.23 |
| Beta | 1.23 |
| Volatility | 77.58% |
| Current Volume | 196.3k |
| Average Volume 20d | 333.4k |
What is the price of ICAD stocks?
As of December 22, 2024, the stock is trading at USD 1.83 with a total of 196,310 shares traded.
Over the past week, the price has changed by -6.15%, over one month by +18.45%, over three months by +15.82% and over the past year by +10.91%.
As of December 22, 2024, the stock is trading at USD 1.83 with a total of 196,310 shares traded.
Over the past week, the price has changed by -6.15%, over one month by +18.45%, over three months by +15.82% and over the past year by +10.91%.
Is icad inc a good stock to buy?
No, based on ValueRay Fundamental Analyses, icad inc (NASDAQ:ICAD) is currently (December 2024) a stock to sell. It has a ValueRay Fundamental Rating of -56.86 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ICAD as of December 2024 is 1.36. This means that ICAD is currently overvalued and has a potential downside of -25.68%.
No, based on ValueRay Fundamental Analyses, icad inc (NASDAQ:ICAD) is currently (December 2024) a stock to sell. It has a ValueRay Fundamental Rating of -56.86 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ICAD as of December 2024 is 1.36. This means that ICAD is currently overvalued and has a potential downside of -25.68%.
Is ICAD a buy, sell or hold?
icad inc has received a consensus analysts rating of 4.75. Therefor, it is recommend to buy ICAD.
icad inc has received a consensus analysts rating of 4.75. Therefor, it is recommend to buy ICAD.
- Strong Buy: 3
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecast for ICAD stock price target?
According to ValueRays Forecast Model, ICAD icad inc will be worth about 1.5 in December 2025. The stock is currently trading at 1.83. This means that the stock has a potential downside of -16.94%.
According to ValueRays Forecast Model, ICAD icad inc will be worth about 1.5 in December 2025. The stock is currently trading at 1.83. This means that the stock has a potential downside of -16.94%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 4.4 | 139.3% |
| Analysts Target Price | 4.9 | 166.7% |
| ValueRay Target Price | 1.5 | -16.9% |